Literature DB >> 22608996

Protecting a serial killer: pathways for perforin trafficking and self-defence ensure sequential target cell death.

Jamie A Lopez1, Amelia J Brennan, James C Whisstock, Ilia Voskoboinik, Joseph A Trapani.   

Abstract

Considerable progress has been made in understanding how cytotoxic lymphocytes use the highly toxic pore-forming protein perforin to eliminate dangerous cells, while remaining refractory to lysis. At least two mechanisms jointly preserve the killer cell: the C-terminal residues of perforin dictate its rapid export from the endoplasmic reticulum (ER), whose milieu otherwise favours pore formation; perforin is then stored in secretory granules whose acidity prevent its oligomerisation. Following exocytosis, perforin delivers the proapoptotic protease, granzyme B, into the target cell by disrupting its plasma membrane. Although the precise mechanism of perforin/granzyme synergy remains controversial, the recently defined crystal structure of the perforin monomer and cryo-electron microscopy (EM) of the entire pore suggest that passive transmembrane granzyme diffusion is the dominant proapoptotic mechanism.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608996     DOI: 10.1016/j.it.2012.04.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  34 in total

Review 1.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

2.  Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylation.

Authors:  Imran G House; Colin M House; Amelia J Brennan; Omer Gilan; Mark A Dawson; James C Whisstock; Ruby Hp Law; Joseph A Trapani; Ilia Voskoboinik
Journal:  EMBO Rep       Date:  2017-08-14       Impact factor: 8.807

3.  The preclinical pharmacokinetic disposition of a series of perforin-inhibitors as potential immunosuppressive agents.

Authors:  M R Bull; J A Spicer; K M Huttunen; W A Denny; A Ciccone; K A Browne; J A Trapani; N A Helsby
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-08-26       Impact factor: 2.441

4.  Anti-myeloma activity and molecular logic operation by Natural Killer cells in microfluidic droplets.

Authors:  Saheli Sarkar; Seamus McKenney; Pooja Sabhachandani; James Adler; Xiaozhe Hu; Dina Stroopinksy; Jacalyn Rosenblatt; David Avigan; Tania Konry
Journal:  Sens Actuators B Chem       Date:  2018-11-17       Impact factor: 7.460

5.  Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.

Authors:  Kenneth M Kaufman; Bolan Linghu; Joseph D Szustakowski; Ammar Husami; Fan Yang; Kejian Zhang; Alexandra H Filipovich; Ndate Fall; John B Harley; N R Nirmala; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

Review 6.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

7.  Calcium-dependent permeabilization of erythrocytes by a perforin-like protein during egress of malaria parasites.

Authors:  Swati Garg; Shalini Agarwal; Saravanan Kumar; Syed Shams Yazdani; Chetan E Chitnis; Shailja Singh
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 8.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

9.  Perforin-dependent cytotoxicity: 'Kiss of death' or prolonged embrace with darker elocation-idnseque11es?

Authors:  Joseph A Trapani; Ilia Voskoboinik; Misty R Jenkins
Journal:  Oncoimmunology       Date:  2015-04-14       Impact factor: 8.110

10.  Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.

Authors:  Joanna Baginska; Elodie Viry; Guy Berchem; Aurélie Poli; Muhammad Zaeem Noman; Kris van Moer; Sandrine Medves; Jacques Zimmer; Anaïs Oudin; Simone P Niclou; R Chris Bleackley; Ing Swie Goping; Salem Chouaib; Bassam Janji
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.